triethylenemelamine has been researched along with Polycythemia Vera in 4 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Polycythemia Vera: A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
ELLISON, RR | 1 |
GINSBERG, V | 1 |
WATSON, J | 1 |
ROSENTHAL, N | 1 |
ROSENTHAL, RL | 1 |
Stecher, G | 1 |
Reinhardt, G | 1 |
4 other studies available for triethylenemelamine and Polycythemia Vera
Article | Year |
---|---|
Triethylenemelamine in polycythemia vera; a therapeutic trial.
Topics: Humans; Polycythemia Vera; Triethylenemelamine | 1953 |
Treatment of polycythemia vera with triethylene melamine; summary of thirty cases.
Topics: Polycythemia Vera; Triethylenemelamine | 1952 |
Chemotherapy in polycythemia vera.
Topics: Busulfan; Humans; Leukemia; Leukemia, Myeloid; Phosphorus Isotopes; Polycythemia Vera; Primary Myelo | 1968 |
Pipobroman (Vercyte) - a new antineoplastic drug.
Topics: Anemia, Hemolytic; Antineoplastic Agents; Bone Marrow; Busulfan; Chlorambucil; Gastrointestinal Hemo | 1967 |